{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:00:04Z","timestamp":1770919204524,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/s1470-2045(09)70089-0","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T05:39:50Z","timestamp":1251437990000},"page":"920-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?"],"prefix":"10.1016","volume":"10","author":[{"given":"Maria Isabel Waddington","family":"Achatz","sequence":"first","affiliation":[]},{"given":"Pierre","family":"Hainaut","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"Ashton-Prolla","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(09)70089-0_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0004.2006.00692.x","article-title":"Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers","volume":"70","author":"Borry","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.ejhg.5201822","article-title":"Communicating genetic information in families\u2014a review of guidelines and position papers","volume":"15","author":"Forrest","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib3","first-page":"1","article-title":"American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility","volume":"21","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(09)70089-0_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/pch\/8.1.42","article-title":"Guidelines for genetic testing of healthy children. A joint statement with the Canadian College of Medical Geneticists","volume":"8","year":"2003","journal-title":"Paediatr Child Health"},{"key":"10.1016\/S1470-2045(09)70089-0_bib7","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(09)70089-0_bib8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1470-2045(09)70089-0_bib9","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","article-title":"Relative frequency and morphology of cancers in carriers of germline TP53 mutations","volume":"20","author":"Birch","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S1470-2045(09)70089-0_bib10","first-page":"6643","article-title":"Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(09)70089-0_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","article-title":"Prediction of pathogenic mutations in patients with early-onset breast cancer by family history","volume":"361","author":"Lalloo","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2005.12.039","article-title":"The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families","volume":"245","author":"Achatz","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/S1470-2045(09)70089-0_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2007.10.044","article-title":"Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil","volume":"261","author":"Palmero","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/S1470-2045(09)70089-0_bib14","unstructured":"Piovesan GC. Prevalence of the R337H TP53 allele in the State of Paran\u00e1. Thesis, Federal University of Paran\u00e1, Brazil, 2006 (in Portuguese)."},{"key":"10.1016\/S1470-2045(09)70089-0_bib15","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1470-2045(09)70089-0_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.2004.030551","article-title":"Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation","volume":"43","author":"Figueiredo","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-8-357","article-title":"Association of the germline TP53 R337H mutation with breast cancer in southern Brazil","volume":"8","author":"Assump\u00e7\u00e3o","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/S1470-2045(09)70089-0_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US Preventive Services Task Force","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1470-2045(09)70089-0_bib20","first-page":"281","article-title":"Principles and practice of mass screening for disease","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"10.1016\/S1470-2045(09)70089-0_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1470-2045(09)70089-0_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"10.1016\/S1470-2045(09)70089-0_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmg.2005.037952","article-title":"Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome","volume":"43","author":"Bougeard","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6690313","article-title":"Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome","volume":"80","author":"Burt","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(09)70089-0_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.9-1-13","article-title":"Recognition and management of hereditary breast cancer syndromes","volume":"9","author":"Thull","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/S1470-2045(09)70089-0_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2005.10.014","article-title":"Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome","volume":"130","author":"Wong","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/S1470-2045(09)70089-0_bib27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.299.11.1315","article-title":"F18-fluorodeoxyglucosepositron emission tomography\/computed tomography screening in Li-Fraumeni syndrome","volume":"299","author":"Masciari","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S1470-2045(09)70089-0_bib28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results in 253-patient series from the French Association of Endocrine Surgeons Study Group","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/S1470-2045(09)70089-0_bib30","first-page":"389","article-title":"Newborn screening: a blueprint for the future executive summary: newborn screening taskforce report","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/S1470-2045(09)70089-0_bib31","first-page":"122","article-title":"A public health response to emerging technology: expansion of the Massachussets newborn screening program","volume":"116","author":"Atkinson","year":"2001","journal-title":"Public Health Rep"},{"key":"10.1016\/S1470-2045(09)70089-0_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"AmericanThoracic Society\/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S1470-2045(09)70089-0_bib33","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/S1470-2045(09)70089-0_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMoa012387","article-title":"Screening of infants and mortality due to neuroblastoma","volume":"346","author":"Woods","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(09)70089-0_bib35","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/dji203","article-title":"Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening","volume":"97","author":"Soderstrom","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(09)70089-0_bib36","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/jnci\/84.15.1156","article-title":"Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals","volume":"84","author":"Li","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(09)70089-0_bib37","first-page":"581","article-title":"Li-Fraumeni syndrome: update, new data and guidelines for clinical management","volume":"88","author":"Frebourg","year":"2001","journal-title":"Bull Cancer"},{"key":"10.1016\/S1470-2045(09)70089-0_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.mph.0000140650.65591.f1","article-title":"Predictive genetic testing for childhood cancer: taking the road less traveled by","volume":"26","author":"Malkin","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/S1470-2045(09)70089-0_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cancergencyto.2007.09.015","article-title":"A rare tumor and an ethical dilemma in a family with a germline TP53 mutation","volume":"180","author":"Prochazkova","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S1470-2045(09)70089-0_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajmg.c.30158","article-title":"\u201cYou're one of us now\u201d: young people describe their experiences of predictive genetic testing for Huntington Disease (HD) and familial adenomatous polyposis (FAP)","volume":"148C","author":"Duncan","year":"2008","journal-title":"Am J Med Genet C"},{"key":"10.1016\/S1470-2045(09)70089-0_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajmg.c.30161","article-title":"Living with genetic risk: effect on adolescent self concept","volume":"148C","author":"McConkie-Rosell","year":"2008","journal-title":"Am J Med Genet C"},{"key":"10.1016\/S1470-2045(09)70089-0_bib42","first-page":"147","article-title":"An exploration of the legal and socio-ethical implications of predictive genetic testing of children","volume":"18","author":"Otlowski","year":"2004","journal-title":"Aust J Fam Law"},{"key":"10.1016\/S1470-2045(09)70089-0_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.seminoncol.2007.07.007","article-title":"Ethical and legal aspects of cancer genetic testing","volume":"34","author":"Offit","year":"2007","journal-title":"Semin Oncol"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204509700890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204509700890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:00:11Z","timestamp":1761458411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204509700890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1470204509700890"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(09)70089-0","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(09)70089-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}